Skip to content

Influencing Factors and Short-Term Outcomes of Hyperthyrotropinemia in Late Preterm Infants

Influencing Factors and Short-Term Outcomes of Hyperthyrotropinemia in Late Preterm Infants

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500115326
Enrollment
Unknown
Registered
2025-12-24
Start date
2026-01-20
Completion date
Unknown
Last updated
2026-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperthyrotropinemia

Interventions

Hyperthyrotropinemia group and non-hyperthyrotropinemia group:None

Sponsors

Shanhai Sixth People’s Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 1 Years

Inclusion criteria

Inclusion criteria: 1. Late preterm infants 2. First thyroid function test performed between 5 and 21 days after birth 3. Cases of hyperthyrotropinemia (HT) with elevated TSH concentration and FT4 within the normal range. 4. Subsequent regular treatment and follow-up of thyroid function and growth development 5. Complete clinical data of both newborns and mothers available.

Exclusion criteria

Exclusion criteria: 1. Newborns with congenital genetic metabolic diseases, positive thyroid-related antibodies, birth defects, multi-organ dysfunction, or chromosomal abnormalities; 2. Mothers with neoplastic diseases, major organ dysfunction, autoimmune diseases, or long-term use of immunosuppressive or glucocorticoid medications; 3. Infants who did not undergo scheduled follow-ups or with incomplete clinical data.

Design outcomes

Primary

MeasureTime frame
Thyroid-Stimulating Hormone;

Secondary

MeasureTime frame
Free Thyroxine;

Countries

China

Contacts

Public ContactLi Xiaofeng

Shanhai Sixth People’s Hospital

19856259918@163.com+86 198 5625 9918

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026